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Iowa PMP Update
As of December 31, 2014, 5,147 prescribers have registered 
to use the Iowa Prescription Monitoring Program (PMP) (an 
increase of 14.5% from one year ago) and 2,390 pharmacists 
have registered to use the program (an increase of 15% from 
one year ago). Between January 1, 2014 and December 31, 
2014, a total of 239,852 requests for data were submitted to the 
program (an increase of 35% from one year ago). The program 
has registered 721 practitioner agents (an increase of 70% from 
one year ago). The program is continuing to reduce the inci-
dence of patients who utilize multiple pharmacies and multiple 
prescribers to obtain controlled substances (CS) in Iowa. The 
number of patients filling prescriptions for Schedule II, III, and 
IV CS and utilizing five or more prescribers or pharmacists has 
fallen from 3,293 in 2009 to 527 in 2014 (a decrease of 84%). 
In the past six years, the number of doses of CS dispensed to 
patients in Iowa has grown by 18%, from 228,149,732 doses in 
2009 to 269,466,402 doses in 2014.
An Iowa PMP Conference was held in Johnston, IA, on 
February 10, 2015, co-sponsored by the Iowa Board of Phar-
macy and the Governor’s Office of Drug Control Policy. The 
conference included a review and discussion of other state 
PMPs; a comparison of Iowa’s PMP to other state PMPs; Iowa 
PMP success stories; the impact of the Iowa PMP on prescrib-
ing practitioners, pharmacists, and patients; and needs for the 
future. Recommendations as a result of the conference will be 
forthcoming.
Pharmacy Support Persons in Iowa
 As of January 2015, there are 1,792 pharmacy support per-
sons (PSPs) registered in Iowa. Since 2010, the number of PSPs 
in Iowa has grown by 140% from 746. Each Iowa pharmacy 
has approximately two PSPs per pharmacy location. Board 
administrative rules relating to PSPs are contained in 657 
Iowa Administrative Code (IAC) Chapter 5. It is important to 
be aware of the functions that PSPs may and may not perform 
in Iowa pharmacies.
Subrule 657 IAC §5.18 provides the following tasks that 
PSPs may perform.
1. The duties of a pharmacy clerk (eg, placing prescription 
container into bag)
2. Processing of drug orders from wholesaler/supplier
3. Routine clerical duties (eg, filing paperwork)
4. Updating or changing patient demographic information in 
the pharmacy computer, excluding allergies and disease 
state information
5. Receiving a prescription refill request from a patient
6. Drug inventory duties, including checking for outdated 
drugs
7. Delivering drugs to patient care areas
8. Any routine pharmacy support function not prohibited in 
Subrule 657 IAC §5.17
9. Nonjudgmental tasks in a nuclear pharmacy if under the 
direct supervision of a nuclear pharmacist
Subrule 657 IAC §5.17 provides the following tasks that 
PSPs shall not perform.
1. Providing the final verification for a filled prescription or 
medication order
2. Conducting prospective drug use review or evaluating a 
patient’s medical record
3. Providing patient counseling or patient-specific drug 
information
4. Making decisions that require a pharmacist’s professional 
judgment
5. Receiving new or refill prescription orders from prescrib-
ers or their agents
6. Providing a prescription or drug to a patient without a phar-
macist’s verification and in the absence of a pharmacist
7. Packaging, pouring, or placing drugs into containers for 
subsequent dispensing to patients, including reconstitu-
tion of oral antibiotic liquids
8. Affixing prescription labels to prescription containers for 
dispensing to patients
9. Processing or entering patient or prescription information 
into the pharmacy computer system, except as provided 
in Subrule §5.18(4)
10. Prepackaging or labeling multi-dose and single-dose 
packages of drugs, including dose picks for unit-dose cart 
fills in hospitals and long-term care facilities
11. Checking or inspecting drug supplies located outside of 
the pharmacy department
12. Reconstituting prefabricated noninjectable medications, 
preparing parenteral products, or compounding sterile or 
nonsterile drug products
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adsorbed, and inactivated poliovirus (DTaP-IPV); tetanus toxoid, 
reduced diphtheria toxoid, and acellular pertussis adsorbed (Tdap); 
diphtheria, tetanus toxoid, and acellular pertussis adsorbed (DTaP); 
hepatitis A (HepA); hepatitis B (HepB); human papillomavirus 
quadrivalent (types 6, 11, 16, and 18), recombinant (HPV4); zoster; 
and measles, mumps, rubella, and varicella (MMRV). The most 
common contributing factors associated with the reported vaccine 
errors included mistakes in choosing age-dependent formulations of 
vaccines intended to prevent the same diseases; unfamiliarity with 
the vaccine, particularly its dose, dosing schedule, age specifica-
tions, route of administration, and the vaccine’s various components 
(eg, combination vaccines, diluents, and powder); failure to check 
or verify the patient’s age, health record, or state registry; similar 
vaccine names and abbreviations; similar and confusing vaccine 
labeling and packaging; unsafe storage conditions (eg, stored near 
other similar vaccines or unwanted temperature fluctuations); and 
expiration dates not noticed or misunderstood.
Practice Recommendations. Involve the patient or parent(s)/
caregiver(s) in a vaccine verification process by:
1) Documenting the vaccine name, formulation (pediatric or 
adult, if applicable), lot number, and expiration date on the 
patient’s vaccine record prior to preparation/administration 
of the vaccine,
2) Bringing the vial and syringe or the prefilled syringe along 
with the immunization record into the exam room,
3) Asking the patient or parent/caregiver to simultaneously 
verify the information on the immunization record while a 
health care provider reads the information on the label aloud,
4) Asking the patient or parent/caregiver if the verified vaccine 
is what he or she expected to be administered (based on an 
immunization schedule provided to the patient or parent/
caregiver previously),
5) Preparing and administering the vaccine immediately after 
verification, and
6) Documenting the vaccine on the patient’s medical record.
FDA Warns of Growing Network of Rogue 
Wholesale Drug Distributors
Through a new educational program called Know Your Source, 
Food and Drug Administration (FDA) is warning pharmacists and 
other health care providers to watch for counterfeit and unapproved 
drugs. Aimed at protecting patients from unsafe and ineffective 
drugs, the program advises providers to only purchase drugs from 
wholesale drug distributors licensed in their state. Further, FDA 
offers tips to providers to protect patients, including being wary 
of offers too good to be true, and ensuring that all drugs received 
are FDA-approved medications.
Another way that pharmacies can be assured of the legitimacy 
of a wholesale distributor is to look for the National Association 
of Boards of Pharmacy® (NABP®) Verified-Accredited Wholesale 
Distributors® (VAWD®) Seal. Those wholesale distributors that 
achieve VAWD accreditation are in compliance with state and 
federal laws, as well as NABP’s VAWD criteria. Wholesale dis-
tributors that display the VAWD Seal as part of their accreditation 
have undergone a criteria compliance review, including a rigorous 
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DEA Finalizes Rule on CS Prescription Drug 
Disposal
In September 2014, Drug Enforcement Administration (DEA) 
published its final rule, titled the Disposal of Controlled Substances, 
that allows some DEA registrants to modify their registration to 
become authorized collectors. Under the new rule, some DEA 
registrants, including retail pharmacies, hospitals/clinics with an 
on-site pharmacy, manufacturers, distributors, reverse distributors, 
and narcotic treatment programs, may modify their registration with 
DEA to become authorized collectors. The final rule implements the 
Secure and Responsible Drug Disposal Act of 2010, which autho-
rized DEA to develop and implement regulations that would allow 
authorized entities other than law enforcement to collect unused 
and unwanted prescription drugs, including controlled substances 
(CS), for disposal purposes. Proper disposal of unused prescription 
medication is a key method of preventing and reducing prescription 
drug abuse. The final rule took effect on October 9, 2014.
The full rule is available on the Federal Register website at www 
.federalregister.gov/articles/2014/09/09/2014-20926/disposal-of-
controlled-substances.
System-Based Causes of Vaccine Errors
This column was prepared by the Institute 
for Safe Medication Practices (ISMP). 
ISMP is an independent nonprofit agency 
and federally certified patient safety organization that analyzes 
medication errors, near misses, and potentially hazardous 
conditions as reported by pharmacists and other practitioners. 
ISMP then makes appropriate contacts with companies and 
regulators, gathers expert opinion about prevention measures, and 
publishes its recommendations. To read about the risk reduction 
strategies that you can put into practice today, subscribe to ISMP 
Medication Safety Alert!® Community/Ambulatory Care Edition 
by visiting www.ismp.org. ISMP provides legal protection and 
confidentiality for submitted patient safety data and error reports. 
Help others by reporting actual and potential medication errors to 
the ISMP National Medication Errors Reporting Program Report 
online at www.ismp.org. Email: ismpinfo@ismp.org.
Immunizations are widely recognized as one of the most suc-
cessful and cost-effective health interventions ever introduced 
worldwide. However, errors with vaccines can result in an un-
intended and unrecognized source of vulnerability. While the 
immediate impact of a vaccine-related error on a patient may 
not be serious, such errors may render the vaccine ineffective or 
reduce its effectiveness, leaving patients unprotected against seri-
ous diseases such as hepatitis A, hepatitis B, diphtheria, tetanus, 
measles, cervical cancer, and many others. In September 2012, 
ISMP (in cooperation with the California Department of Public 
Health) established the ISMP National Vaccine Errors Reporting 
Program (VERP) to collect data about the type of vaccine errors 
occurring and the reasons they occur. In ISMP’s November 28, 
2013 newsletter (www.ismp.org/sc?id=307), ISMP provided a 
summary analysis of error reports submitted to the ISMP VERP 
during its first year. The vaccinations that are most frequently 
associated with errors included Haemophilus influenzae type b 
conjugate (Hib); diphtheria and tetanus toxoids, acellular pertussis 
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review of their operating policies and procedures, licensure verifi-
cation, survey of facility and operations, background checks, and 
screening through the NABP Clearinghouse. Accredited facilities 
are reviewed annually and undergo a site survey every three years. 
Created in 2004, the accreditation program plays a pivotal role in 
preventing counterfeit drugs from entering the United States drug 
supply.
Additional information about the VAWD program is available 
in the Programs section of the NABP website. Know Your Source 
is available at www.fda.gov/Drugs/ResourcesForYou/Health 
Professionals/ucm389121.htm.
PTCB Implements Changes to CE 
Requirements
In 2015, the Pharmacy Technician Certification Board (PTCB) 
will implement two changes in recertification requirements for 
certified pharmacy technicians (CPhTs) in accordance with its certi-
fication program changes announced in 2013. First, any continuing 
education (CE) hours earned by a CPhT will need to be pharmacy 
technician-specific in order to qualify toward recertification. Sec-
ond, PTCB will reduce the number of allowable “in-service” CE 
hours from 10 to five. PTCB’s certification program changes are 
intended to support and advance improved patient care and safety 
throughout pharmacy practice, a PTCB press release indicates. The 
changes are the result of a PTCB initiative that began with a 2011 
summit on future directions for pharmacy technicians.
Additional information can be accessed on the PTCB website 
at www.ptcb.org.
Security Guidelines Available as Rate of 
Pharmacy Robberies Still a Concern
Nationally, pharmacy robberies dipped slightly from 745 in 
2012, to 713 in 2013, according to a report compiled by Drug Topics 
using DEA statistics. The 10 states that had the most robberies 
are in stark contrast to other states that had no robberies (South 
Dakota, North Dakota, and Alaska) or as few as one or two (such 
as Montana and Illinois), reports Drug Topics. However, fueled 
by the prescription drug abuse epidemic, pharmacy robberies still 
pose a threat to the safety of personnel and customers. The report 
lists the top 10 states that had the most pharmacy thefts in 2013. 
Arizona experienced the most pharmacy robberies in 2013 with 
77 incidents, and Indiana took second place with 71 robberies. The 
report, titled “Top 10 states for pharmacy robberies,” may be found 
at http://drugtopics.modernmedicine.com/drug-topics/content/tags/
arizona/top-10-states-pharmacy-robberies?page=full. 
NABP partnered with DEA to create an educational pamphlet 
identifying key strategies pharmacists can take to secure their stores 
against robberies, which can be downloaded at www.deadiversion 
.usdoj.gov/pubs/brochures/pharmtheft.pdf. In addition, some 
boards of pharmacy have identified best practices for preventing 
pharmacy theft, and have supported these practices through regu-
lations or recommendations for their licensees. For example, the 
New Jersey State Board of Pharmacy’s Pharmacy Security Best 
Practices document recommends that all Schedule II and III CS 
be stored in a “safe or substantially constructed steel cabinet that is 
locked at all times,” with only licensed pharmacists having access. 
Additional recommendations include annual pharmacist-in-charge 
self-assessments and interfacing with prescribers and customers, 
among others. The best practices document can be downloaded 
from the New Jersey Consumer Affairs website at www.njconsumer 
affairs.gov/press/05012013.pdf.
Private organizations have also developed resources to assist phar-
macies in improving security.  One such resource is the RxPATROL 
program, which works with law enforcement, the pharmacy com-
munity, and security professionals to maintain a database containing 
detailed information about pharmacy robberies and other losses. 
In addition, the RxPATROL website, www.rxpatrol.com, provides 
training videos and a pharmacy security checklist.
Further, NABP members directed the Association to convene 
a task force to review strategies that states have taken to prevent 
theft and drug diversion. The Task Force to Examine Strategies for 
Preventing and Reacting to Pharmacy Robberies and Thefts met 
on October 22-23, 2014, to discuss these issues.
Assured Brand Naproxen Tablets Recalled 
Due to Packaging Error
In October 2014, Contract Packaging Resources of Greensboro, 
NC, a drug repackaging company, issued a voluntary recall of 
nearly 12,000 boxes of Assured brand naproxen sodium tablets 
because some cartons contain bottles of 200 mg ibuprofen softgels 
instead, a press release posted to the FDA website indicates. The 
packaging error affected boxes of Assured brand naproxen sodium 
tablets 220 mg, 15 count (Lot Number FH4102A), which were 
distributed to and sold at Dollar Tree stores and on the Dollar Tree 
website. Contract Packaging Resources is contacting customers to 
arrange for replacement of all recalled products. Adverse reactions 
or quality problems experienced with the use of this product may be 
reported to FDA’s MedWatch Adverse Event Reporting Program.
More information is available on the FDA website at www.fda 
.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHuman 
MedicalProducts/ucm419769.htm.
Martin Avenue Pharmacy Issues Voluntary 
Recall for All Sterile Compounded 
Preparations
Martin Avenue Pharmacy, Inc, of Naperville, IL, issued a volun-
tary recall for all in-date compounded sterile preparations due to a 
lack of sterility assurance in August 2014. Following a recent FDA 
inspection that revealed “quality control procedures that present 
a risk to sterility assurance,” the company issued the recall out of 
an abundance of caution, indicates a news release posted to the 
FDA website. Martin Avenue Pharmacy supplied compounded 
sterile preparations to offices of licensed medical professionals and 
individuals in multiple states including Illinois, Wisconsin, Ohio, 
Michigan, Florida, Alabama, and Texas until August 20, 2014. 
A full list of recalled products is available on the Martin Avenue 
Pharmacy website (registration required). FDA urges consumers 
and health care providers to report adverse events or side effects 
related to the use of these products to FDA’s MedWatch Safety 
Information Adverse Event Reporting Program.
More information is available on the FDA website at www.fda 
.gov/Safety/Recalls/ucm412431.htm.
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13. Transferring prescriptions between pharmacies
14. Assisting with or witnessing the destruction or wastage 
of CS
15. Performing any of the technical duties of a pharmacy 
technician who is registered pursuant to 657 IAC Chap-
ter 3
The Board’s application form for registration as a pharmacy 
support person is available for download on the Board’s website 
at www.state.ia.us/ibpe/pdf/58.pdf.
50-Year Pharmacists
The Board congratulates the following 26 Iowa pharma-
cists who were originally licensed in 1965, have continuously 
maintained their Iowa pharmacist license, and have devoted a 
half-century of service to the public and the profession:
 ♦ Edward P. Bean, Wayland, IA
 ♦ Maurice D. Bell, Afton, IA
 ♦ Terry M. Carley, Avoca, IA
 ♦ Larry P. Costello, Clear Lake, IA
 ♦ Gary A. Daws, Dixon, IL
 ♦ John L. Drzycimski, Cedar Rapids, IA
 ♦ Marvin T. Feidler, Phoenix, AZ
 ♦ Gerald H. Getter, Corning, IA
 ♦ Duane J. Haberichter, Oskaloosa, IA
 ♦ Charles S. Haigh, West Des Moines, IA
 ♦ Stephen G. Haigh, Des Moines, IA
 ♦ John R. Hofmann, Green Bay, WI
 ♦ Lois A. Hurst, Runnells, IA
 ♦ Corliss H. Klaassen, Chariton, IA
 ♦ David E. Johnson, Burlington, IA
 ♦ Robert S. McCaffrey, Boone, IA
 ♦ Roger D. Nichols, Prairie City, IA
 ♦ Martin N. Ogden, Olathe, KS
 ♦ Stephen E. Peterson, Bettendorf, IA
 ♦ John M. Phillips, Newton, IA
 ♦ Carl E. Rouse, Centerville, IA
 ♦ Wayne K. Ruhl, Melrose, IA
 ♦ Darrell J. Shirk, Gravois Mills, MO
 ♦ Robert P. Shores, New London, IA
 ♦ William F. Sievers, Jr, Sioux City, IA
 ♦ Roger W. Snook, Council Bluffs, IA
Board Meeting Calendar – 2015
The Board plans to hold regular meetings on the following 
dates at the Board office in Des Moines:
 ♦ March 9-11,
 ♦ April 28-29,
 ♦ June 23-24,
 ♦ September 1-2, and
 ♦ November 3-4, 2015.
Please contact the Board office at 515/281-5944 to confirm 
times and location.
Board Website
Please visit the Board’s website at www.state.ia.us/ibpe for 
more information.
Board Mission
The Iowa Board of Pharmacy promotes, preserves, and 
protects the public health, safety, and welfare through the ef-
fective regulation of the practice of pharmacy and the licensing 
of pharmacies, pharmacists, and others engaged in the sale, 
delivery, or distribution of prescription drugs and devices. 
Iowa Code §155A.2(1).
Follow the Board on Facebook and Twitter
Continued from page 1
Facebook “Iowa Board of Pharmacy”
www.facebook.com/pages/Iowa-Board-of-
Pharmacy/223126781053672
Twitter “IABoardPharmacy”
http://twitter.com/#!/IABoardPharmacy
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